Activation of cytotoxic T lymphocyte responses and attenuation of tumor growth in vivo by Andrographis paniculata extract and andrographolide

Immunopharmacology and Immunotoxicology

Volumn 29, Issue 1, 2007, Pages 81-93

  Sheeja, K ^a   Kuttan, G ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

Alloimmunization; Andrographis Paniculata; Andrographolide; Cytotoxic T Cells; Interferon ; Interleukin 2; Winn's Neutralization Assay

Indexed keywords

ANDROGRAPHIS PANICULATA EXTRACT; ANDROGRAPHOLIDE; GAMMA INTERFERON; INTERLEUKIN 2;

ALLOIMMUNIZATION; ANIMAL CELL; ARTICLE; ATTENUATION; BAGG ALBINO MOUSE; CANCER INHIBITION; CELL ACTIVATION; CELL SURVIVAL; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; IN VITRO STUDY; IN VIVO STUDY; LIFESPAN; LYMPHOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SERODIAGNOSIS; SPLEEN CELL; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; T LYMPHOCYTE; TARGET CELL; TUMOR GROWTH;

ANDROGRAPHIS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DITERPENES; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; IMMUNITY, CELLULAR; INTERFERON TYPE II; INTERLEUKIN-2; MICE; MICE, INBRED BALB C; PLANT PREPARATIONS; T-LYMPHOCYTES, CYTOTOXIC; THYMOMA;

ANDROGRAPHIS PANICULATA; ANIMALIA; MUS;

EID: 34247606683     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.1080/08923970701282726     Document Type: Article

References (36)

1. Singh, N.P.; Yolcu, E.S.; Taylor, D.D.; Gercel-Taylor, C.; Metzinger, D.S.; Dreisbach, S.K.; Shirwan, H. A novel approach to cancer immunotherapy: tumor cell decorated with CD80 generate effective antitumor immunity. Cancer Res. 2003 (63), 4067-4073.
2. Tarazona, R.; Casado, J.G.; Soto, R.; Dela Rosa, O.; Peralho, E.; Rioja, L.; Pena, J.; Solana, R. Expression of NK- associated receptors on cytotoxic T cells from melanoma patients. Cancer Immunol. Immunother. 2004 (53), 911-924.
3. Liu, Y.; Ng, K.; Lillehei, K.O. Cell-mediated immunotherapy: a new approach to the treatement of malignant glioma. Cancer Control 2003 (10),138-146.
4. Sykulev,Y.; Jou, M.; Vturina, I.; Tsomides, T.J.; Eisen, H.N. Evidence that single Peptide-MHC complex on a target cell elicit cytolytic T cell response. Immunity 1996, (4), 565-571.
5. Qin, Z.; Schwartzkopft, J.; Pradera, F.; Kammertoens, T.; Seliger, B.; Pircher, H.; Blankenstein, T.A. Critical requirement of interferon gamma mediated angiostasis for tumor rejection by CD8+ T cells. Cancer Res. 2003 (63), 4095-4100.
6. Abe, R.; Peng, T.; Sailors, J.; Bucala, R.; Metz, C.N. Regulation of the CTL response by macrophage migration inhibitory factor. J. Immunol. 2001 (166), 747-753.
7. Sunila, E.S.; Kuttan, G. Immunomodulatory and antitumor activity of Piper longum Linn. and Piperine. J. Ethnopharmacol. 2004 (90), 339-346.
8. Mirandola, L.; Justo, G.Z.; Queiroz, M.L.S. Modulation by Acanthospermum australe extracts of the tumor induced hematopoietic changes in mice. Immunopharmacol. Immunotoxi 2002, (24), 275-288.
9. Tram, N.T.N.; Zvetkova, E.; Nikolova, E.; Katzarova, E.; Kostov, G.; Yanchev, I.; Baichev, O. A novel in vitro and in vivo T- lymphocyte activating factor in Crinum latifolium (L.) aqueous extracts. Exp. Pathol. Parasitol. 1999 (30), 21-26.
10. Zhao, H.Y.; Fang, W.Y. Antithrombotic effect of Andrographis paniculata nees in preventing myocardial infraction. Chin. Med. J. (Engl). 1991 (104), 770-775.
11. Zhang, C.Y.; Tan, B.K. Mechanisms of cardiovascular activity of Andrographis paniculata in the anaesthetized rat. J. Ethnopharmacol. 1997 (56), 97-101.
12. Wang, D.W.; Zhao, H.Y. Prevention of atherosclerotic arterial stenosis and restenosis after angioplasty with Andrographis paniculata nees and fish oil. Chin. Med. J. (Engl). 1994 (107), 464-470.
13. Visen, P.K.S.; Shukla, B.; Patnaik, G.K. Andrographolide protects rat hepatocytes against paracetamol-induced damage. J. Ethnopharmacol. 1993 (40), 131-136.
14. Zhang, X.F.; Tan, X.F. Anti-diabetic property of ethanolic extract of Andrographis paniculata in streptozotocin-diabetic rats. Acta Pharmacol. Sin. 2000 (21), 1157-1164.
15. Shen, Y.C.; Chen, C.F.; Chiou, W.F. Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism (s) involved in its antiinflamatory effect. Br. J. Pharmacol. 2002 (135), 399-406.
16. Kapil, A.; Koul, I.B.; Banerjee, S.K. Antihepatotoxic effects of major diterpenoid constituents of Andrographis paniculata. Biochem. Pharmacol. 1993 (46), 182-185.
17. Handa, S.S., Sharma, A. Hepatoprotective activity of Andrographolide from Andrographis paniculata against carbontetrachloride. Ind. J. Med. Res. 1990 (92), 276-283.
18. Kobayashi, H.; Aso, H.; Ishida, N.; Meida, H.; Schmith, D. A.; Pollard, R.B.; Suzuki, F. Determination of CTL activity by winn's neutralization.
19. Kempf, R.A.; Mitchell, M.S. Effect of chemotherapeutic agents on the immune response II. Cancer Invest. 1985 (3), 23-33.
20. Santin, A.D.; Hermonat. P.L.; Ravaggi, A.; Bellone, S.; Roman, J.; Pecorelli, S.; Cannon, M.; Parham, G.P. Effect of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix. Int. J. Radiat. Oncol. Biol. Phys. 2000 (48), 997-1006.
21. Tsavaris, N.; Kosmas, C.; Vadiaka, M.; Kanelopoulos, P.; Boulamatsis. D. Immune changes in patients with advanced breast cancer undergoing chemotherapy with Taxanes. Br. J. Cancer 2002 (87), 21-27.
22. Holladay, F.P.; Heitz,T.; Wood, G.W. Antitumor activity against established intracerebral gliomas exhibited by cytotoxic T lymphocyte, but not by lymophokine-activated killer cells. J. Neurosurg. 1992 (77), 757-762.
23. Maher, J.; Davies, E.T. Targeting cytotoxic T lymphocyte for cancer immunotherapy. Br. J. Cancer 2004 (91), 817-821.
24. Rooney, C. M.; Aguilar, L.K.; Huls, M.H.; Brenner, M.K.; Heslop, H.E. Adoptive immunotherapy of EBV-associated malignancies with EBV-specific cytotoxic T cell lines. Curr. Top. Microbiol. Immunol. 2001 (258), 221-229.
25. Fast, L.D. Recipient CD8+ cells are responsible for the rapid elimination of allogeneic donor lymphoid cells. J. Immunol. 1996 (157), 4805-4810.
26. + T cell-based immunotherapy interferes with liver tumor progression in a transgenic mouse models. J. Immunol. 1998 (161), 5133-5137.
27. Suzuki, R.; Suzuki, S.; Ebina, N.; Kumagai, K. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cell and restoration by interferon and or interleukin 2. J. immunol. 1985 (134), 2139-2148.
28. Marie, J. E.; Alistair, J. R.; Andrew, B.; Scott, A.T.; Coralie, J.M.; Ian, A.R. Prime-boost immunization generates a high frequency, high-avidity CD8+ ytotoxic T lymphocyte population. IntL. Immunol. 2002 (14), 31-37.
29. Gorer, P.A. Studies in antibody response of mice to tumor inoculation. Br. J. Cancer 1950 (4), 372-379.
30. Sanda, W.; Akiko, U.; Eiichi, N. Immune responses against allogeneic and syngeneic tumors in aged C57BL/6 mice. Microbiol. Immunol. 2002 (46), 513-519.
31. Rourke, A.M.O.; Mescher, M.F. The role of CD8 in cytotoxic T lymphocyte function. Immunol.Today 1993 (14), 183-188.
32. Taylor, M.K.; Cohen, J.J. Cell-mediated cytotoxicity. Curr. Opin. Immunol. 1992 (4), 338-343.
33. Berke, G. Lymphocyte-triggered internal target disintegration. Immunol. Today 1991 (12), 396-399.
34. Mei-Ping, C.; Norman, D.C. Ethanol impairs major histocompatibility complex (MHC) Class II molecule mediated but not MHC Class I molecule mediated T cell response in alcohol-consumed mice, Immunopharmacol. Immunotoxi 1999 (21), 65-87.
35. Kern, D. E.; Gillis, S.; Okada, M.; Henney, C.S. The role of interleukin-2 (IL-2) in the differentiation of cytotoxic T cells: the effect on monoclonal antibody and absorption with IL-2 dependent cell lines. J. Immunol. 1981 (127), 1323-1328. assay. Immunopharmacol. Immunotoxicol. 1992 (14), 841-848.
36. Yuka, T.; Hideki, O.; Takashi, O.; Toshimasa, A. Multiparameter flow cytometric approach for simultaneous evaluation of proliferation and cytokine-secreting activity in T cells responding to allo-stimulation. Immunol. Invest. 2004 (33), 309-324.